IGC Pharma, Inc.
IGC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326205
No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in IGC Pharma, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 25
- −2 vs. Q3 2023
- Shares held
- 2.47M
- −356.1K (−12.6%) vs. Q3 2023
- Total value
- $691.3K
- −$322.1K (−31.8%) vs. Q3 2023
- New holders
- 5
- 5 more added
- Sold out
- 7
- 4 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IGC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 36 | $1.41M |
| Q1 2026 | 35 | $1.14M |
| Q4 2025 | 30 | $1.36M |
| Q3 2025 | 35 | $2.27M |
| Q2 2025 | 28 | $929.4K |
| Q1 2025 | 25 | $814.9K |
| Q4 2024 | 30 | $954.3K |
| Q3 2024 | 23 | $1.19M |
| Q2 2024 | 25 | $1.11M |
| Q1 2024 | 25 | $943.4K |
| Q4 2023 | 25 | $691.3K |
| Q3 2023 | 27 | $1.01M |
| Q2 2023 | 23 | $827.5K |
| Q1 2023 | 23 | $917.6K |
| Q4 2022 | 26 | $937.3K |
| Q3 2022 | 26 | $1.31M |
| Q2 2022 | 29 | $1.73M |
| Q1 2022 | 29 | $3.97M |
| Q4 2021 | 29 | $6.07M |
| Q3 2021 | 32 | $7.90M |
| Q2 2021 | 29 | $7.90M |
| Q1 2021 | 29 | $7.97M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding IGC Pharma, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 717,884 | $201.1K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 645,166 | $180.7K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 324,296 | $90.9K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 184,107 | $51.6K | 0.00% | 00.0% | Unchanged |
| Dearborn Partners LLC | 116,710 | $32.7K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 76,872 | $21.5K | 0.00% | +22,321+40.9% | Added |
| Northern Trust Corp | 71,364 | $20.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 69,000 | $19.3K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 65,495 | $18.3K | 0.00% | −10.0% | Reduced |
| Virtu Financial LLC | 60,723 | $17.0K | 0.00% | −9,273−13.2% | Reduced |
| Group One Trading, L.P. | 60,459 | $16.9K | 0.00% | −1,100−1.8% | Reduced |
| Truist Financial Corp | 36,667 | $10.3K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 23,317 | $6.53K | 0.00% | +1,982+9.3% | Added |
| JPMorgan Chase & Co | 4,917 | $1.38K | 0.00% | +4,917 | New |
| UBS Group AG | 4,747 | $1.33K | 0.00% | +4,453+1,514.6% | Added |
| Geneos Wealth Management Inc. | 3,000 | $840 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,032 | $288 | 0.00% | −1,082−51.2% | Reduced |
| Morgan Stanley | 860 | $241 | 0.00% | +50+6.2% | Added |
| Game Plan Financial Advisors, LLC | 500 | $140 | 0.00% | +500 | New |
| Wells Fargo & Company | 373 | $104 | 0.00% | +74+24.7% | Added |
| Caitlin John, LLC | 200 | $56 | 0.00% | +200 | New |
| FMR LLC | 156 | $44 | 0.00% | +156 | New |
| DHJJ Financial Advisors, Ltd. | 80 | $23 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 25 | $7 | 0.00% | +25 | New |
| Toronto Dominion Bank | 6 | $2 | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −165,490−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −86,902−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −47,750−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −46,540−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −18,148−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −14,276−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −250−100.0% | Sold out |